Login to stream the interview below – or access our private podcast. If you don't have a login, subscribe for free now!
The Baker T2D & Heart Failure Miniseries (Part 7)
The coexistence of cardiovascular disease (CVD) nearly doubles the mortality rate in individuals with Type 2 Diabetes, who often face earlier and more severe complications. As frontline clinicians, GPs play a pivotal role – cardiovascular risk assessment isn’t just important; it’s lifesaving.
In this episode, we cover the key questions: Who’s being overlooked? Who stands to benefit the most? Who is best positioned to intervene? How frequently should assessments happen? What needs to change in practice? And most crucially, how do we effectively communicate the importance of these assessments to our patients?
Join us as we unpack practical strategies to integrate CVD risk evaluation into your consultations, both opportunistically and through scheduled health checks, to make a real difference in outcomes for your patients with Type 2 Diabetes.
GP, Platinum Medical Centre, Chermside, Brisbane.
Deputy Director, The Baker Heart & Diabetes Institute, & Council member of Australian Diabetes Society.
GP Edition 164
Supported by: Produced by DrivetimeRadio with the support of The Baker Heart and Diabetes Institute in collaboration with Boehringer Ingelheim. Produced April 2025.
Tap the share icon
and select 'Add to Home Screen' to add the site to your home screen for quick access!